Search - tctmd.com

Displaying 661 - 680 of 800

Sort: Relevancy | Date

Presentation TCT 2017

DEFCON 1: Defusing Interpersonal Conflicts in the Cath Lab

Presenter: Robert J. Applegate, Daniel M. Kolansky, Hadley Wilson

October 31, 2017

Presentation TCT 2017

Establishing a Safety Culture in the Cath Lab

Presenter: Robert J. Applegate, Daniel M. Kolansky, Arnold Seto

October 31, 2017

Presentation TCT 2017

The Role and Responsibilities of the Cath Lab Manager

Presenter: Robert J. Applegate, Daniel M. Kolansky, Bernadette S. Speiser

October 31, 2017

Presentation TCT 2017

Assuring Success of the Medical Director

Presenter: Robert J. Applegate, Daniel M. Kolansky

October 31, 2017

Presentation TCT 2017

Welcome and Introduction

Presenter: Robert J. Applegate, Daniel M. Kolansky

October 31, 2017

Presentation TCT 2017

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Presenter: Roxana Mehran, George A. Mensah

October 31, 2017

Presentation TCT 2017

Featured Lecture: Disparities Among Healthcare Providers and Optimal Cardiovascular Care Pathways in Underserved Populations - Realities and Solutions

Presenter: Roxana Mehran, George A. Mensah, Cheryl Pegus

October 31, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Major Device Company Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Donald E. Bobo Jr

October 30, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Start-up Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Rick Geoffrion

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Presenter: Andrew Farb, Aaron V. Kaplan, Jaime Walkowiak

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in USA: Status Update Report from the FDA

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

EFS: Articulating the Value for the Entire Ecosystem

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Presenter: Wayne B. Batchelor, George A. Mensah

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Presenter: Wayne B. Batchelor, George A. Mensah, Cindy L. Grines

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Presenter: Wayne B. Batchelor, George A. Mensah, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Presenter: Wayne B. Batchelor, George A. Mensah, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

Presenter: Wayne B. Batchelor, George A. Mensah, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Advertisement

DEFCON 1: Defusing Interpersonal Conflicts in the Cath Lab

Establishing a Safety Culture in the Cath Lab

The Role and Responsibilities of the Cath Lab Manager

Assuring Success of the Medical Director

Welcome and Introduction

Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce

Featured Lecture: Disparities Among Healthcare Providers and Optimal Cardiovascular Care Pathways in Underserved Populations - Realities and Solutions

EFS Experiences and Recommendations: A Major Device Company Perspective

EFS Experiences and Recommendations: A Start-up Perspective

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Early Feasibility Studies in USA: Status Update Report from the FDA

EFS: Articulating the Value for the Entire Ecosystem

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

The Landscape of CV Device Innovation for Children: Regulatory View

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content